Health
Capricor Therapeutics Faces FDA Rejection for Duchenne Treatment
By Editor • August 20, 2026 • 1 min read
Capricor Therapeutics' efforts to prevent FDA rejection of its Duchenne muscular dystrophy treatment appear futile, requiring a new clinical trial for approval.
Read more